Content :
Oncology
Products organised per phase
| Phase |
Product |
Product |
Product |
Product |
Product |
| Approved / Launched / LCM |
ELOXATIN®
oxaliplatin
Metastatic colorectal K;
new IV formulation; Colon
K adjuvant, EU/US;
Pediatric, US
|
FASTURTEC®/ELITEK®
rasburicase
Malignancy/chemotherapy-
associated hyperuricemia
|
TAXOTERE®
docetaxel
US/EU/Japan: Breast K; Lung K;
Gastric K;
US/EU: Prostate K; Neoadjuvant H&N K
Japan/US: H&N K; Ovary K;
Esophagus K; Endometrial K.
|
- |
- |
| Submitted |
TAXOTERE®
docetaxel
Prostate K, Japan
|
- |
- |
- |
- |
| Phase III |
S-1
Oral fluoropyrimidine
anticancer agent
Gastric K, Colorectal K,
Pancreatic K
|
aflibercept
VEGF-Trap
(AVE0005)
Single: Ovarian K;
Combo: 1st line mProstate;
2nd line NSCLC, 2nd line mCRC, 1st
line mPancreatic K
|
alvocidib
(HMR1275)
Cyclin-dependent
kinase inhibitor
CLL
|
XRP6258
Taxoid,
Tubulin inhibitor
Prostate K
|
larotaxel
(XRP9881)
Taxoid,
Tubulin inhibitor
Pancreatic K
Bladder K
|
| Phase III |
xaliproden
(SR57746)
Neurotrophic
Peripheral sensory
neuropathies
|
TroVax®
(SAR109659)
Renal K
|
AVE8062
Vascular disrupting agent
Sarcoma
|
TAXOTERE®
docetaxel
Pediatric
|
- |
| Phase IIb |
FASTURTEC®/ELITEK®
rasburicase
Malignancy/chemotherapy-
associated hyperuricemia, Japan
|
larotaxel
(XRP9881)
Taxoid, Tubulin inhibitor
Early Breast K
|
- |
- |
- |
| Phase IIa |
XRP6258/ larotaxel
Taxoid, Tubulin inhibitor
mBreast K
|
- |
- |
- |
- |
| Phase I |
AVE1642
Anti-IGF-1R
naked mAb
Multiples myeloma; solid tumors
|
SAR3419
Maytansin-loaded
anti-CD19 mAb
Non-Hodgkin's lymphoma
|
AVE9633
Maytansin-loaded
anti-CD33 mAb
Acute Myeloid Leukemia
|
SSR97225
Antimitotic agent
|
SSR244738
Antitumoral agent
|
| Preclinical |
SAR103168
Multikinase inhibitor
AML
|
SAR131675
VEGFR3-TK inhibitor
|
SAR132885
CENP-E and alpha tubulin binding
cytototix agent inhibitor
Solid tumors
|
SAR566658
Maytansin-loaded
anti-DS6 mAb
Solid tumors
|
SAR567530
HSP90 inhibitor
Solid tumors
|
| Preclinical |
SAR650984
Anti-CD38 naked mAb
Liquid tumors
|
- |
- |
- |
- |
R&D portfolio presented on February 12, 2008
|
